Holen Sie sich die Stockscreener-App
9.7558
0.51%
-0.0342
Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
47.31%
60.07
|
114.00 | 56.86 | - | - |
| Operating Income/Loss |
47.31%
-60.07
|
-114.00 | -56.86 | - | - |
| Nonoperating Income/Loss |
14.63%
6.353
|
5.542 | 3.837 | - | - |
| Income/Loss From Continuing Operations Before Tax |
50.47%
-53.72
|
-108.46 | -53.03 | -38.54 | -35.62 |
| Income/Loss From Continuing Operations After Tax |
50.59%
-53.72
|
-108.73 | -53.03 | -38.54 | -35.62 |
|
Net Income/Loss
|
50.59%
-53.72
|
-108.73 | -53.03 | -38.54 | -35.62 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
433.72%
157.94
|
29.59 | 46.69 | - | - |
| Diluted Average Shares |
433.72%
157.94
|
29.59 | 46.69 | - | - |
| Basic Earnings Per Share |
750.00%
-0.34
|
-0.04 | -1.14 | - | - |
| Diluted Earnings Per Share |
750.00%
-0.34
|
-0.04 | -1.14 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):